
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1284-1291
Closed Access | Times Cited: 108
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1284-1291
Closed Access | Times Cited: 108
Showing 1-25 of 108 citing articles:
Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 27
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 27
Lifetime risk and projected burden of dementia
Michael Fang, Jiaqi Hu, Jordan Weiss, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
Michael Fang, Jiaqi Hu, Jordan Weiss, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4
Femke M. Feringa, Sascha J. Koppes-den Hertog, Lian Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Femke M. Feringa, Sascha J. Koppes-den Hertog, Lian Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Brain health clinics – An evolving clinical pathway?
Anneka F Butters, Jonathan Blackman, Hannah Farouk, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100051-100051
Open Access | Times Cited: 1
Anneka F Butters, Jonathan Blackman, Hannah Farouk, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100051-100051
Open Access | Times Cited: 1
The impact of rare genetic variants on Alzheimer disease
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease
Alessandro Padovani, Alice Galli, Elena Bazzoli, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
Alessandro Padovani, Alice Galli, Elena Bazzoli, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
The Glutamate/GABA ‐Glutamine Cycle: Insights, Updates, and Advances
Jens V. Andersen
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Open Access | Times Cited: 1
Jens V. Andersen
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Open Access | Times Cited: 1
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6683-6683
Open Access | Times Cited: 6
Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6683-6683
Open Access | Times Cited: 6
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’s Disease
John A. Hey, Susan Abushakra, Kaj Blennow, et al.
Drugs (2024) Vol. 84, Iss. 7, pp. 811-823
Open Access | Times Cited: 6
John A. Hey, Susan Abushakra, Kaj Blennow, et al.
Drugs (2024) Vol. 84, Iss. 7, pp. 811-823
Open Access | Times Cited: 6
Challenges to identifying risk versus protective factors in Alzheimer’s disease
Chiara Pappalettera, Claudia Carrarini, Stefano F. Cappa, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3094-3095
Closed Access | Times Cited: 6
Chiara Pappalettera, Claudia Carrarini, Stefano F. Cappa, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3094-3095
Closed Access | Times Cited: 6
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3800-3827
Open Access | Times Cited: 6
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3800-3827
Open Access | Times Cited: 6
APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer’s pathology: New findings from the ADNI
Aravind Lathika Rajendrakumar, Konstantin G. Arbeev, Olivia Bagley, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316808-e0316808
Open Access
Aravind Lathika Rajendrakumar, Konstantin G. Arbeev, Olivia Bagley, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316808-e0316808
Open Access
GWAS of CRP response to statins further supports the role of APOE in Statin Response: a GIST consortium study
Emma Magavern, Harshal Deshmukh, Géraldine Asselin, et al.
Pharmacological Research (2025), pp. 107575-107575
Open Access
Emma Magavern, Harshal Deshmukh, Géraldine Asselin, et al.
Pharmacological Research (2025), pp. 107575-107575
Open Access
Influence of APOE ε4 on performance of CSF biomarkers in differentiating clinical Alzheimer's disease
Yan Wang, Fangyu Li, Qi Qin, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100065-100065
Open Access
Yan Wang, Fangyu Li, Qi Qin, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100065-100065
Open Access
APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology
Kristine M. Tran, Nellie Kwang, Claire A. Butler, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Kristine M. Tran, Nellie Kwang, Claire A. Butler, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
A case of chronic lymphocytic leukaemia with initial symptoms of cognitive impairment
Baoye Ye, Yilin Huang, W. Lai
Research Square (Research Square) (2025)
Closed Access
Baoye Ye, Yilin Huang, W. Lai
Research Square (Research Square) (2025)
Closed Access
The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease
J. Wesson Ashford
Journal of Alzheimer s Disease (2025)
Closed Access
J. Wesson Ashford
Journal of Alzheimer s Disease (2025)
Closed Access
Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis
Wei I. Jiang, Yiming Cao, Yue Xue, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Wei I. Jiang, Yiming Cao, Yue Xue, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Predicting conversion in cognitively normal and mild cognitive impairment individuals with machine learning: Is the CSF status still relevant?
Mirella Russo, Davide Nardini, Sara Melchiorre, et al.
Alzheimer s & Dementia (2025)
Open Access
Mirella Russo, Davide Nardini, Sara Melchiorre, et al.
Alzheimer s & Dementia (2025)
Open Access
APOE4 and sedentary lifestyle synergistically impair neurovascular function in the visual cortex of awake mice
Silvia Anderle, Orla Bonnar, Joseph B. Henderson, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Silvia Anderle, Orla Bonnar, Joseph B. Henderson, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Uncovering dark mass in population proteomics: Pan-analysis of single amino acid polymorphism relevant to cognition and aging
Xiaojing Gao, Yuanyuan Yin, Yiqian Chen, et al.
Cell Genomics (2025), pp. 100763-100763
Open Access
Xiaojing Gao, Yuanyuan Yin, Yiqian Chen, et al.
Cell Genomics (2025), pp. 100763-100763
Open Access
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
Beyza Mertaş, İffet İpek Boşgelmez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1222-1222
Open Access
Beyza Mertaş, İffet İpek Boşgelmez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1222-1222
Open Access
Unveiling the link between APOE ε4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study
Mohamed Khaled, Hadi Al-Jamal, Dana B. Matar, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Mohamed Khaled, Hadi Al-Jamal, Dana B. Matar, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Impact of APOE , Klotho, and sex on cognitive decline with aging
Kengo Shibata, Cheng Chen, Xin You Tai, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Kengo Shibata, Cheng Chen, Xin You Tai, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Generalizable Prediction of Alzheimer Disease Pathologies with a Scalable Annotation Tool and an High-Accuracy Model
V. Ramaswamy, Monika Ahirwar, Gennadi Ryan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
V. Ramaswamy, Monika Ahirwar, Gennadi Ryan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access